Matches in Wikidata for { <http://www.wikidata.org/entity/Q37226536> ?p ?o ?g. }
- Q37226536 description "article científic" @default.
- Q37226536 description "article scientifique" @default.
- Q37226536 description "articolo scientifico" @default.
- Q37226536 description "artigo científico" @default.
- Q37226536 description "artículu científicu espublizáu en 2013" @default.
- Q37226536 description "bilimsel makale" @default.
- Q37226536 description "scientific article published on 24 September 2013" @default.
- Q37226536 description "vedecký článok" @default.
- Q37226536 description "vetenskaplig artikel" @default.
- Q37226536 description "videnskabelig artikel" @default.
- Q37226536 description "vědecký článek" @default.
- Q37226536 description "wetenschappelijk artikel" @default.
- Q37226536 description "wissenschaftlicher Artikel" @default.
- Q37226536 description "наукова стаття, опублікована у вересні 2013" @default.
- Q37226536 description "научни чланак" @default.
- Q37226536 description "مقالة علمية نشرت في 24 سبتمبر 2013" @default.
- Q37226536 name "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.
- Q37226536 name "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.
- Q37226536 name "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.
- Q37226536 type Item @default.
- Q37226536 label "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.
- Q37226536 label "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.
- Q37226536 label "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.
- Q37226536 prefLabel "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.
- Q37226536 prefLabel "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.
- Q37226536 prefLabel "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.
- Q37226536 P1104 Q37226536-8289BAD5-19D8-4FA1-8E31-640B0274DF4B @default.
- Q37226536 P1433 Q37226536-A393E1E0-D6AD-4D98-979D-FA201F6E9DFA @default.
- Q37226536 P1476 Q37226536-D87917FF-E8A5-45D0-8901-6C67DC49CE98 @default.
- Q37226536 P2093 Q37226536-5211012D-9FDD-41DA-B68E-5F0402441126 @default.
- Q37226536 P2093 Q37226536-56974191-3C93-49DD-8219-04B7727697AD @default.
- Q37226536 P2093 Q37226536-62A02F5D-2065-4F5F-80F1-6C8D94C0ECA0 @default.
- Q37226536 P2093 Q37226536-6E986B4B-10C2-406A-9325-2C22DABD3282 @default.
- Q37226536 P2093 Q37226536-740FEB44-1BF7-4D8A-B428-059BD2A8CAD5 @default.
- Q37226536 P2093 Q37226536-7CBCED35-A035-4E17-BFA3-4FF5E4D8902A @default.
- Q37226536 P2093 Q37226536-81458CFF-C833-42EB-A3BA-AD0461D544FC @default.
- Q37226536 P2093 Q37226536-B652D02B-DACC-466E-B9A9-01091C0E4D68 @default.
- Q37226536 P2093 Q37226536-CADCC490-335E-442E-B3CD-39718E9832EE @default.
- Q37226536 P2093 Q37226536-F6867B17-9F57-4B96-B78E-A2CAC4BD1D1C @default.
- Q37226536 P275 Q37226536-95c90e22-066c-49ed-bd59-65ed3ba412a8 @default.
- Q37226536 P2860 Q37226536-17D97559-5747-44F9-8289-58227408BD3A @default.
- Q37226536 P2860 Q37226536-1EC0CAD7-B192-4315-B71C-DCCE532F12A5 @default.
- Q37226536 P2860 Q37226536-232882EB-83D5-446A-A0C9-93B0845A40E8 @default.
- Q37226536 P2860 Q37226536-24E9D40E-2CBB-45C7-A53A-4BA5DDD5C22F @default.
- Q37226536 P2860 Q37226536-2886100F-31DE-4CFE-9CB8-DBB5C3A9AE5F @default.
- Q37226536 P2860 Q37226536-297BFB1C-4D8A-48DC-A667-C13783B23944 @default.
- Q37226536 P2860 Q37226536-2B77BC38-A6CF-4701-B62F-EF721531E7A6 @default.
- Q37226536 P2860 Q37226536-3A6CED3E-4B7E-4429-B36A-C0F139DC35B3 @default.
- Q37226536 P2860 Q37226536-41A92BB0-AE68-4E2F-806B-29060564B73A @default.
- Q37226536 P2860 Q37226536-47805316-9143-4C5C-8AB8-4A753476B04A @default.
- Q37226536 P2860 Q37226536-56B3C6DA-7807-453D-B568-41E7955F5200 @default.
- Q37226536 P2860 Q37226536-642B17FD-07A5-4946-997F-168AF2E68E06 @default.
- Q37226536 P2860 Q37226536-67F94D0E-67D9-4815-9211-3EC927BE695A @default.
- Q37226536 P2860 Q37226536-68901AE9-CBCA-4FFC-81E0-A97784C7B9C4 @default.
- Q37226536 P2860 Q37226536-6D2D7002-2416-48E3-B410-E0DBB71976A1 @default.
- Q37226536 P2860 Q37226536-71873267-BF00-4D43-90DD-DE0241970F58 @default.
- Q37226536 P2860 Q37226536-7E9419A8-EF02-4673-A3F5-FC22DCCEFC40 @default.
- Q37226536 P2860 Q37226536-805E4836-C043-4D6E-A3B3-C02A2D91A0E7 @default.
- Q37226536 P2860 Q37226536-823D5A4B-5FBD-4117-9B0E-7E578E677C2D @default.
- Q37226536 P2860 Q37226536-86E02F15-40DB-4E6F-AB1D-135F1819A11A @default.
- Q37226536 P2860 Q37226536-8897A426-24B5-4BEA-845B-BEEB73F85287 @default.
- Q37226536 P2860 Q37226536-89D7E343-D31B-4529-A8F3-27128350CBF7 @default.
- Q37226536 P2860 Q37226536-90E46AD6-C910-4142-8573-72439CF9DF4E @default.
- Q37226536 P2860 Q37226536-94BBABB7-FF62-4B52-B9BC-DA3F70E49D80 @default.
- Q37226536 P2860 Q37226536-94E9A264-78A3-44C6-AEF2-F539DC9A1E8F @default.
- Q37226536 P2860 Q37226536-9F8805AF-F0CD-4AB8-9ACE-7EDA8C3973D6 @default.
- Q37226536 P2860 Q37226536-A7983D63-A063-44AC-B02B-07A770F9186E @default.
- Q37226536 P2860 Q37226536-B50DEA3B-4BAC-41A8-9A2A-EC236D1AF8FF @default.
- Q37226536 P2860 Q37226536-C16AA63E-3244-4473-9162-0476C98622FA @default.
- Q37226536 P2860 Q37226536-C4F40832-DC2D-482F-9CE5-A5715EA6FFF6 @default.
- Q37226536 P2860 Q37226536-CA98ACFC-674D-4632-9281-E889B9D358C6 @default.
- Q37226536 P2860 Q37226536-CED9C9D8-FD9A-417D-96A0-16DDA896EF3D @default.
- Q37226536 P2860 Q37226536-D073DC55-C7A4-40DB-833C-728C7C2D4E8E @default.
- Q37226536 P2860 Q37226536-D6746891-3B97-4B94-8830-2FEAF90F52FA @default.
- Q37226536 P2860 Q37226536-D6BB2E73-FC06-4DD0-B58E-EDA798050A82 @default.
- Q37226536 P2860 Q37226536-D6BE1EE4-5BAF-4F11-BCF8-93E3E3FD7619 @default.
- Q37226536 P2860 Q37226536-E5B4F194-C2D8-484D-BF16-FCD7BDEE721E @default.
- Q37226536 P2860 Q37226536-E823E5CA-4CF1-4C21-9D3E-C669B348DA66 @default.
- Q37226536 P2860 Q37226536-F7C7E886-8547-48BA-8203-6E5B88576253 @default.
- Q37226536 P2860 Q37226536-FC69C8F0-7BE3-4AD0-BD3D-D1F13A10C885 @default.
- Q37226536 P2860 Q37226536-FF358CCE-858F-4C38-8345-82776F2F13CE @default.
- Q37226536 P304 Q37226536-344E28F8-7BB5-48B9-8D38-657239519D5F @default.
- Q37226536 P31 Q37226536-A27A8143-20BD-4D6D-8C0E-ED6EB1AB3231 @default.
- Q37226536 P356 Q37226536-7540A93A-5EEC-4D29-BBEC-BB2869485308 @default.
- Q37226536 P433 Q37226536-61D81117-8A32-415F-9B30-8D84620FA875 @default.
- Q37226536 P478 Q37226536-A3020026-BC72-4E0B-BB1A-99F944A42F79 @default.
- Q37226536 P50 Q37226536-4E81F412-541E-4220-A7C5-57DB6F08AC34 @default.
- Q37226536 P577 Q37226536-4426272E-2091-410D-9F76-E807C12E056C @default.
- Q37226536 P5875 Q37226536-F6CC51A2-D414-430A-B8AB-95A952C22959 @default.
- Q37226536 P6216 Q37226536-13e44775-732a-4e65-af0f-3dfd7b45c38b @default.
- Q37226536 P698 Q37226536-875CDC95-8BBD-4C6D-A2E4-9253DEC4F620 @default.
- Q37226536 P921 Q37226536-35C2DB7D-7E4E-409C-8594-A8B2542678A2 @default.
- Q37226536 P921 Q37226536-71EE1796-EB38-4561-A8E8-3975F094890E @default.
- Q37226536 P921 Q37226536-E243DDED-2B36-4C16-8A72-BB02E8A40BEB @default.
- Q37226536 P932 Q37226536-82B3CEAB-3604-4A7C-B2C2-1A51D3AEED58 @default.
- Q37226536 P356 CANCERS5031177 @default.
- Q37226536 P698 24202340 @default.
- Q37226536 P1104 "+22" @default.
- Q37226536 P1433 Q27722963 @default.
- Q37226536 P1476 "Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy" @default.